|
FY2026
12 months to Jun 30, 2026
|
FY2025
12 months to Jun 30, 2025
|
FY2024
12 months to Jun 30, 2024
|
FY2023
12 months to Jun 30, 2023
|
FY2022
12 months to Jun 30, 2022
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of products sold | |||||
| Gross profit | |||||
| Selling and administrative expenses | |||||
| Advertising costs | |||||
| Research and development costs | |||||
| Loss on divestiture | |||||
| Pension settlement charge | |||||
| Goodwill, trademark and other asset impairments | |||||
| Interest expense | |||||
| Other (income) expense, net | |||||
| Earnings before income taxes | |||||
| Income taxes | |||||
| Net earnings | |||||
| Less: Net earnings attributable to noncontrolling interests | |||||
| Net earnings attributable to Clorox | |||||
| Net earnings per share attributable to Clorox | |||||
| Basic net earnings per share (in dollars per share) | |||||
| Diluted net earnings per share (in dollars per share) | |||||
| Weighted average shares outstanding (in thousands) | |||||
| Basic (in shares) | |||||
| Diluted (in shares) |
Loading...
